Free from Publisher

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, A Maryandyshev… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …
被引用次数：189 相关文章
[PDF] researchgate.net

[PDF][PDF] Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, A Maryandyshev, M Dalcolmo… - Eur Respir …, 2019 - researchgate.net
ABSTRACT The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …
[HTML] qdcxjkg.com

[HTML][HTML] Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, A Maryandyshev… - European Respiratory …, 2019 - qdcxjkg.com
The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report

S Borisov, E Danila, A Maryandyshev… - EUROPEAN …, 2019 - irinsubria.uninsubria.it
Abstract The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

S Borisov, E Danila, A Maryandyshev… - The European …, 2019 - sonar.ch
English The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report

S Borisov, E Danila, A Maryandyshev… - EUROPEAN …, 2019 - cris.unibo.it
Abstract The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report

S Borisov, E Belilovski, A Filippov, E Danila… - European Respiratory …, 2019 - elibrary.ru
The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

S Borisov, E Danila, A Maryandyshev… - The European …, 2019 - folia.unifr.ch
English The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, A Maryandyshev… - Eur Respir …, 2019 - Eur Respiratory Soc
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Page 1 Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

S Borisov, E Danila, A Maryandyshev… - The European …, 2019 - europepmc.org
The World Health Organization (WHO) recommends that countries implement
pharmacovigilance and collect information on active drug safety monitoring (aDSM) and …